The effect of shock wave therapy on improving the symptoms and function of patients with Dupuytren's contracture

Taheri, Parisa; Salek, Najmeh; Mousavi, Maryam; Maghroori, Razieh

The effect of shock wave therapy on improving the symptoms and function of patients with Dupuytren's contracture

Document Type : Original Article

Authors

¹ Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Rheumatology Division, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Introduction: We aimed to evaluate the effect of shock wave therapy on the improvement of symptoms and function of patients with Dupuytren's contracture. Materials and Methods: This research is a pre-post intervention study, conducted among patients referred to the physical medicine clinics of Isfahan during 2019–2020. In this study, subjects experienced shock wave therapy for 6 sessions, each in a week, and improvement of symptoms and function were assessed and compared after the period of study and follow-up (before treatment, 6 weeks after treatment, and 14 weeks after treatment). The pain visual analog scale and disabilities of the arm shoulder and hand questionnaire were completed for all patients at the mentioned time, and the finger contraction angle was also measured by a goniometer over these intervals. Results: Twenty patients, 11 (55%) men and 9 (45%) women participated in the study. The mean and standard deviation of their age was 66.6 ± 7.11 years. The trend of pain severity of patients was continuously and significantly decreasing up to 14 weeks, which implies the effectiveness of the intervention (P < 0.05). Moreover, the patients' functional status improved due to the continuation of the intervention, and its trend was decreasing up to 14 weeks (P < 0.05). As for the contraction angle, there was a continuous and significant decreasing trend until week 14, and the intervention was also effective on the contraction angle (P < 0.05). Conclusion: It can be concluded that shock wave therapy can be effective in improving the symptoms and function of patients with Dupuytren's Contracture.

Keywords

References

1.	Warwick D. Dupuytren's disease: My personal view. J Hand Surg Eur Vol 2017;42:665-72.
2.	Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009;361:968-79.
3.	DiBenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. Prevalence, incidence, and treatments of Dupuytren's disease in the United States: Results from a population-based study. Hand (N Y) 2011;6:149-58.
4.	Zarezadeh A, Layeghi A, Jamaloddini SM. Evaluation of the effects of fasciectomy on finger contracture in patients with Dupuytren's disease. J Isfahan Med Sch 2017;35:285-90.
5.	Anderson ER, Burmester JK, Caldwell MD. Evaluation of a mitochondrial DNA mutation in maternally inherited and sporadic cases of Dupuytren's disease. Clin Med Res 2012;10:122-6.
6.	Geoghegan J, Forbes J, Clark D, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg 2004;29:423-6.
7.	Anthony SG, Lozano-Calderon SA, Simmons BP, Jupiter JB. Gender ratio of Dupuytren's disease in the modern U.S. population. Hand (N Y) 2008;3:87-90.
8.	Al-Qattan MM. Factors in the pathogenesis of Dupuytren's contracture. J Hand Surg Am 2006;31:1527-34.
9.	Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N Y) 2009;4:256-69.
10.	Salari N, Heydari M, Hassanabadi M, Kazeminia M, Farshchian N, Niaparast M, et al. The worldwide prevalence of the Dupuytren disease: A comprehensive systematic review and meta-analysis. J Orthop Surg Res 2020;15:495.
11.	Johnson JD, Pavano C, Rodner C. Dupuytren's disease. In: Essentials of Hand Surgery. 2018 Feb 28:57.
12.	Lanting R, van den Heuvel ER, Werker PM. Clusters in short-term disease course in participants with primary Dupuytren disease. J Hand Surg Am 2016;41:354-61.
13.	Bogdanov I, Rowland Payne C. Dupuytren contracture as a sign of systemic disease. Clin Dermatol 2019;37:675-8.
14.	Kaplan FTD, Crosby NE. Treatment of recurrent Dupuytren disease. Hand Clin 2018;34:403-15.
15.	Binhammer P. Comparative outcomes of Dupuytren disease treatment. Hand Clin 2018;34:377-86.
16.	Rayan GM. Nonoperative treatment of Dupuytren's disease. J Hand Surg Am 2008;33:1208-10.
17.	Eberlin KR, Mudgal CS. Complications of treatment for Dupuytren disease. Hand Clin 2018;34:387-94.
18.	Zhang D, Earp BE, Benavent KA, Blazar P. Collagenase treatment of Dupuytren's disease with minimum 5-year follow-up: Recurrence, reintervention, and satisfaction. Plast Reconstr Surg 2020;146:1071-9.
19.	Betz N, Ott OJ, Adamietz B, Sauer R, Fietkau R, Keilholz L. Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years. Strahlenther Onkol 2010;186:82-90.
20.	Knobloch K, Kuehn M, Vogt PM. Focused extracorporeal shockwave therapy in Dupuytren's disease – A hypothesis. Med Hypotheses 2011;76:635-7.
21.	Aykut S, Aydın C, Öztürk K, Arslanoğlu F, Kılınç CY. Extracorporeal shock wave therapy in Dupuytren's disease. Sisli Etfal Hastan Tip Bul 2018;52:124-8.
22.	Yum JK, Ahn SJ. Extracorporeal shock wave therapy in musculoskeletal disorders. J Korean Orthop Assoc 2018;53:400-6.
23.	Moya D, Ramón S, Schaden W, Wang CJ, Guiloff L, Cheng JH. The role of extracorporeal shockwave treatment in musculoskeletal disorders. J Bone Joint Surg Am 2018;100:251-63.
24.	Stasinopoulos D. Can extracorporeal shock-wave therapy be used for the management of lateral elbow tendinopathy? World J Methodol 2018;8:37-9.
25.	Abdulsalam AJ, Shehab D, Elhady AA, Abraham M. High-energy focused extracorporeal shockwave therapy relieved pain in Dupuytren's disease: A series of seven hands. Eur J Phys Rehabil Med 2019;55:862-4.
26.	Taghizadeh S, Haghighat F, Piroozi S, Karimi A, Nejad DK. The survey and comparison of musculoskeletal disorders of shoulder, arm and hand in taxi and bus drivers in the city of Shiraz in 2016. Arch Rehabil 2018;19:64-75.
27.	Mousavi SJ, Parnianpour M, Abedi M, Askary-Ashtiani A, Karimi A, Khorsandi A, et al. Cultural adaptation and validation of the persian version of the disabilities of the arm, shoulder and hand (DASH) outcome measure. Clin Rehabil 2008;22:749-57.
28.	Zahednezhad S, Salehi R, Tajali S, Borji A. correlation between pain intensity and disability level with some of the impairments in patients with nonspecific low back pain. J Ilam Univ Med Sci 2013;21:10-20.
29.	Ball C, Izadi D, Verjee LS, Chan J, Nanchahal J. Systematic review of non-surgical treatments for early Dupuytren's disease. BMC Musculoskelet Disord 2016;17:1-7.
30.	Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavarria-Xicotencatl P, Duran-Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992;69:2478-83.
31.	Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959;41-A: 635-64.
32.	Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am 2000;25:629-36.
33.	Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: The importance of clear definitions. J Hand Surg Am 2012;37:2095-105.e7.
34.	Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (N Y) 2011;6:250-5.
35.	Aykut S, Aydın C, Öztürk K, Arslanoğlu F, Kılınç CY. Extracorporeal shock wave therapy in Dupuytren's disease. Sisli Etfal Hastan Tip Bul 2018;52:124-8.

Advanced Biomedical Research